Abeona Therapeutics
ABEO
ABEO
93 hedge funds and large institutions have $464M invested in Abeona Therapeutics in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.56% more ownership
Funds ownership: 1.95% → 2.5% (+0.56%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
28% less call options, than puts
Call options by funds: $4.63M | Put options by funds: $6.47M
Holders
93
Holding in Top 10
1
Calls
$4.63M
Puts
$6.47M
Top Buyers
| 1 | +$61.9M | |
| 2 | +$30.4M | |
| 3 | +$28.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.33M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$6.45M | |
| 3 | -$2.85M | |
| 4 |
CHP
Castle Hook Partners
New York
|
-$2.85M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.75M |